Services on Demand
Journal
Article
Indicators
- Cited by SciELO
Related links
- Similars in SciELO
Share
Anales de la Facultad de Medicina
Print version ISSN 1025-5583
Abstract
RUNCIMAN GOZZER, Thanya and CARRACEDO GONZALES, Carlos. Resistance acquired to third generation tyrosine kinase inhibitors in non small cell lung cancer. An. Fac. med. [online]. 2018, vol.79, n.4, pp.327-330. ISSN 1025-5583. http://dx.doi.org/10.15381/anales.v79i4.15639.
Resistance to third-generation tyrosine kinase inhibitors (TKI) is an increasingly frequent event in clinical practice; however, the exact mechanisms by which tumor cells develop such resistance allowing their survival are unknown. A case of resistance to osimertinib (AZD9291) in non small cell lung cancer, evidenced by next generation sequencing (NGS) and its possible therapeutic approach is described.
Keywords : Drug Resistance; Tyrosine; Lung Neoplasms.